LB887                                                                                 LB887
2020                                                                                   2020
                               LEGISLATURE OF NEBRASKA
                            ONE HUNDRED SIXTH LEGISLATURE
                                      SECOND SESSION
                         LEGISLATIVE BILL 887
        Introduced by Arch, 14.
        Read first time January 09, 2020
        Committee: Health and Human Services
 1      A BILL FOR AN ACT relating to prescription drugs; to amend section
 2          71-2478,     Reissue Revised Statutes of    Nebraska,   and section
 3          28-414.01,     Revised Statutes Cumulative Supplement,   2018;   to
 4          authorize pharmacists to adapt prescriptions as prescribed; and to
 5          repeal the original sections.
 6      Be it enacted by the people of the State of Nebraska,
                                               -1-
LB887                                                                                                         LB887
2020                                                                                                           2020
 1          Section       1.      Section         28-414.01,        Revised Statutes Cumulative
 2      Supplement, 2018, is amended to read:
 3          28-414.01 (1) Except as otherwise provided in this section or when
 4      administered directly by a practitioner to an ultimate user, a controlled
 5      substance listed in Schedule III, IV, or V of section 28-405 shall not be
 6      dispensed without a written, oral, or electronic medical order. Such
 7      medical order is     valid for six months after the date of        issuance.
 8      Original prescription information for any controlled substance listed in
  9     Schedule III, IV, or V of section 28-405 may be transferred between
 10     pharmacies for purposes of refill dispensing pursuant to section 38-2871.
11          (2) A prescription for controlled substances listed in Schedule III,
12      IV, or V of section 28-405 must contain the following information prior
13      to being filled by a pharmacist or dispensing practitioner: (a) Patient's
14      name and address, (b) name of the drug, device, or biological, (c)
15      strength of the drug or biological, if applicable, (d) dosage form of the
16      drug or biological, (e) quantity of the drug, device, or biological
17      prescribed, (f) directions for use, (g) date of issuance, (h) number of
18      refills, including pro re nata or PRN refills, not to exceed five refills
19      within six months after the date of     issuance,     (i)        prescribing
20      practitioner's name and address, and (j) Drug Enforcement Administration
 21     number of the prescribing practitioner. If the prescription is a written
22      paper prescription, the paper prescription must contain the prescribing
23      practitioner's manual signature. If the prescription is an electronic
 24     prescription,      the electronic prescription must contain all of    the
25      elements in subdivisions (a) through (j) of this subsection, must be
26      digitally signed, and must be transmitted to and received by the pharmacy
27      electronically to meet all of the requirements of 21 C.F.R. 1311, as the
28      regulation existed on   January       1,    2014,      pertaining to     electronic
29      prescribing of controlled substances.
 30         (3)(a) A pharmacist who is acting in good faith and exercising
31      reasonable care and who has obtained patient consent may do    the
                                                        -2-
LB887                                                                                           LB887
2020                                                                                             2020
 1      following:
 2          (i) Change the quantity of a drug prescribed if:
 3          (A) The prescribed quantity or package size is not commercially
 4      available; or
 5          (B) The change in quantity is related to a change in dosage form;
 6          (ii) Change the dosage form of the prescription if it is in the best
 7      interest of patient care and if the directions for use are also modified
 8      to equate to an equivalent amount of drug dispensed as prescribed;
 9          (iii) Extend a one-time refill for the quantity prescribed in the
10      most recent fill or a thirty-day supply, whichever is less, if in the
11      professional judgment of the pharmacist the drug is essential to sustain
12      the life of the patient or continue therapy for a chronic condition of
13      the patient and failure to dispense the drug to the patient could result
14      in harm to the health of the patient;
15          (iv) Dispense multiple months' supply of a drug if a prescription is
16      written with sufficient refills; and
17          (v) Substitute any drug that has the same active ingredient and
18      dose.
19          (b) A pharmacist who adapts a prescription in accordance with this
20      subsection shall document the adaptation in       the patient's pharmacy
21      record.
22          (4) (3) A controlled substance listed in Schedule III, IV, or V of
23      section 28-405 may be dispensed pursuant to a facsimile of a written,
24      signed paper prescription.   The facsimile of      a written,   signed paper
25      prescription shall serve as    the original written prescription for
26      purposes of this subsection and shall be maintained in accordance with
27      subsection (2) of section 28-414.03.
28          (5) (4) A prescription for a controlled substance listed in Schedule
29      III, IV, or V of section 28-405 may be partially filled if (a) each
30      partial filling is recorded in the same manner as a refilling, (b) the
31      total quantity dispensed in all partial fillings does not exceed the
                                                -3-
LB887                                                                                                   LB887
2020                                                                                                     2020
 1      total quantity prescribed, and (c) each partial filling is dispensed
 2      within six months after the prescription was issued.
 3               Sec. 2. Section 71-2478, Reissue Revised Statutes of Nebraska, is
 4      amended to read:
 5               71-2478 (1) Except as otherwise provided in this section or the
 6      Uniform Controlled Substances Act or except when administered directly by
 7      a practitioner to     an ultimate user,   a legend drug which is    not    a
 8      controlled substance shall not be dispensed without a written, oral, or
 9      electronic prescription. Such prescription shall be valid for twelve
10      months after the date of issuance.
11               (2) A prescription for a legend drug which is not a controlled
12      substance shall contain the following information prior to being filled
13      by   a pharmacist or    practitioner who holds    a pharmacy license under
14      subdivision (1) of section 38-2850: (a) Patient's name, (b) name of the
15      drug, device, or biological, (c) strength of the drug or biological, if
16      applicable, (d) dosage form of the drug or biological, (e) quantity of
17      the drug, device, or biological prescribed, (f) directions for use, (g)
18      date of issuance, (h) number of authorized refills, including pro re nata
19      or PRN refills, (i) prescribing practitioner's name, and (j) if the
20      prescription is        written,         prescribing practitioner's signature.
21      Prescriptions for controlled substances must meet the requirements of
22      sections 28-414 and 28-414.01.
23               (3)(a) A pharmacist who is acting in good faith and exercising
24      reasonable care and who has obtained patient consent may do     the
25      following:
26               (i) Change the quantity of a drug prescribed if:
27               (A) The prescribed quantity or package size is not commercially
28      available; or
29               (B) The change in quantity is related to a change in dosage form;
30               (ii) Change the dosage form of the prescription if it is in the best
31      interest of patient care and if the directions for use are also modified
                                                        -4-
LB887                                                                                             LB887
2020                                                                                               2020
  1     to equate to an equivalent amount of drug dispensed as prescribed;
 2          (iii) Extend a one-time refill for the quantity prescribed in the
 3      most recent fill or a thirty-day supply, whichever is less, if in the
 4      professional judgment of the pharmacist the drug is essential to sustain
  5     the life of the patient or continue therapy for a chronic condition of
  6     the patient and failure to dispense the drug to the patient could result
  7     in harm to the health of the patient;
  8         (iv) Dispense multiple months' supply of a drug if a prescription is
  9     written with sufficient refills; and
 10         (v) Substitute any drug that has the same active ingredient and
 11     dose.
12          (b) A pharmacist who adapts a prescription in accordance with this
13      subsection shall document the adaptation in    the patient's pharmacy
14      record.
15          (4) (3) A written, signed paper prescription may be transmitted to
 16     the pharmacy via facsimile which shall serve as the original written
17      prescription.       An electronic prescription may be     electronically or
 18     digitally signed and transmitted to the pharmacy and may serve as the
 19     original prescription.
20          (5)      (4)    It shall be    unlawful for any person knowingly or
21      intentionally to possess or to acquire or obtain or to attempt to acquire
22      or obtain, by means of misrepresentation, fraud, forgery, deception, or
23      subterfuge,       possession of    any drug substance not classified as    a
24      controlled substance under the Uniform Controlled Substances Act which
 25     can only be lawfully dispensed, under federal statutes in effect on
 26     January 1, 2015, upon the written or oral prescription of a practitioner
 27     authorized to prescribe such substances.
 28         Sec.     3.     Original section      71-2478,    Reissue Revised Statutes of
 29     Nebraska, and section 28-414.01, Revised Statutes Cumulative Supplement,
 30     2018, are repealed.
                                                     -5-
Statutes affected: Introduced: 28-414.01, 71-2478